Clasp Therapeutics

Clasp Tx

Clasp Therapeutics was founded in 2020, is headquartered in Rockville, lists 11–50 employees, and has $150.0M in recorded funding across 1 round.

Headquarters
Rockville
Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$150.0M
Last Round
$150.0M Series AMar 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 8 investors for this company. The full record is or through the API.

About

Clasp Therapeutics is a biotechnology company with dual headquarters in Rockville, Maryland and Cambridge, Massachusetts, developing next-generation T cell engagers (TCEs) for precision immuno-oncology. Originally formed in 2020 as ManaT Bio around mutation-associated neoantigen research from Johns Hopkins scientists Bert Vogelstein and Drew Pardoll, the company rebranded and launched publicly in March 2024 with $150 million in seed and Series A financing from Catalio Capital Management, Third Rock Ventures, Novo Holdings, Vivo Capital, and Cure Ventures. Clasp's TCEs target tumor-specific mutant antigens presented via specific HLA types, aiming to reduce the off-tumor toxicity seen with earlier-generation T cell engagers.

Summary

Clasp Therapeutics is a Biotech company based in Rockville, founded in 2020. It lists 11–50 employees. It has raised $150.0M in total across 1 round, most recently a $150.0M Series A round in Mar 2024. Investors include Catalio Capital Management, Third Rock Ventures and Novo Holdings A/S.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMar 2024
$150.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Clasp Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/clasp-therapeutics"><img src="https://indexed.vc/api/badge/company/clasp-therapeutics" alt="Clasp Therapeutics on Indexed.vc" width="260" height="76" /></a>